
94% of researchers rate our articles as excellent or good
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.
Find out more
CORRECTION article
Front. Bioeng. Biotechnol. , 04 May 2023
Sec. Biomaterials
Volume 11 - 2023 | https://doi.org/10.3389/fbioe.2023.1200532
This article is a correction to:
Therapy of spinal cord injury by folic acid polyethylene glycol amine-modified zeolitic imidazole framework-8 nanoparticles targeted activated M/Ms
A Corrigendum on
Therapy of spinal cord injury by folic acid polyethylene glycol amine-modified zeolitic imidazole framework-8 nanoparticles targeted activated M/Ms
by Li Q, Guo Y, Xu C, Sun J, Zeng F, Lin S and Yuan Y (2022). Front. Bioeng. Biotechnol. 10:959324. doi: 10.3389/fbioe.2022.959324
In the published article, there was an error in Figure 5C as published the authors noticed one error image (SCI group) in Figure 5C. The corrected Figure 5C can be appear below.
FIGURE 5. Anti-inflammation effect of FA-PEG/ZIF-8 in SCI mice. Representative images (A) and quantification analysis (B) of Iba-1 in the spinal cord. Representative images (C) and quantification analysis (D) of Tunel in the spinal cord. Representative images (E) of IL-1β in the spinal cord. Representative images (F) and quantification analysis (G) of IL-1β and cleaved-caspase-3 in the spinal cord via Western blot. Quantification analysis of iNOS (H), IL-1β (I), Arg-1 (J), and IL-10 (K) mRNA levels in the spinal cord. Scale bars, 100 µm. Data are presented as the mean±SD. Two-tailed Student’s t-test.**p < 0.01, ***p < 0.001, ****p < 0.0001.
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Keywords: spinal cord injury, microglia/macrophages, metal-organic frameworks, inflammation, apoptosis same as
Citation: Li Q, Guo Y, Xu C, Sun J, Zeng F, Lin S and Yuan Y (2023) Corrigendum: Therapy of spinal cord injury by folic acid polyethylene glycol amine-modified zeolitic imidazole framework-8 nanoparticles targeted activated M/Ms. Front. Bioeng. Biotechnol. 11:1200532. doi: 10.3389/fbioe.2023.1200532
Received: 06 April 2023; Accepted: 20 April 2023;
Published: 04 May 2023.
Edited by:
Mingqiang Li, Third Affiliated Hospital of Sun Yat-sen University, ChinaReviewed by:
Hani Nasser Abdelhamid, Assiut University, EgyptCopyright © 2023 Li, Guo, Xu, Sun, Zeng, Lin and Yuan. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Sen Lin, YWxkcmluX2xpbkAxNjMuY29t; Yajiang Yuan, MjU1NTkwMjVAcXEuY29t
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Research integrity at Frontiers
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.